Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Increased serum sialic acid is associated with morbidity and mortality in a murine model of dengue disease.

Espinosa DA, Beatty PR, Puerta-Guardo H, Islam MN, Belisle JT, Perera R, Harris E.

J Gen Virol. 2019 Nov;100(11):1515-1522. doi: 10.1099/jgv.0.001319.

PMID:
31526452
2.

Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism.

Puerta-Guardo H, Glasner DR, Espinosa DA, Biering SB, Patana M, Ratnasiri K, Wang C, Beatty PR, Harris E.

Cell Rep. 2019 Feb 5;26(6):1598-1613.e8. doi: 10.1016/j.celrep.2019.01.036.

3.

Cyclic Dinucleotide-Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses.

Espinosa DA, Beatty PR, Reiner GL, Sivick KE, Hix Glickman L, Dubensky TW Jr, Harris E.

J Immunol. 2019 Feb 15;202(4):1153-1162. doi: 10.4049/jimmunol.1801323. Epub 2019 Jan 14.

PMID:
30642979
4.

The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.

Glasner DR, Puerta-Guardo H, Beatty PR, Harris E.

Annu Rev Virol. 2018 Sep 29;5(1):227-253. doi: 10.1146/annurev-virology-101416-041848. Epub 2018 Jul 25. Review.

5.

Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components.

Glasner DR, Ratnasiri K, Puerta-Guardo H, Espinosa DA, Beatty PR, Harris E.

PLoS Pathog. 2017 Nov 9;13(11):e1006673. doi: 10.1371/journal.ppat.1006673. eCollection 2017 Nov.

6.

Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.

Hertz T, Beatty PR, MacMillen Z, Killingbeck SS, Wang C, Harris E.

J Immunol. 2017 May 15;198(10):4025-4035. doi: 10.4049/jimmunol.1700029. Epub 2017 Apr 5.

7.

Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.

Sayce AC, Alonzi DS, Killingbeck SS, Tyrrell BE, Hill ML, Caputo AT, Iwaki R, Kinami K, Ide D, Kiappes JL, Beatty PR, Kato A, Harris E, Dwek RA, Miller JL, Zitzmann N.

PLoS Negl Trop Dis. 2016 Mar 14;10(3):e0004524. doi: 10.1371/journal.pntd.0004524. eCollection 2016 Mar.

8.

Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.

Warfield KL, Plummer EM, Sayce AC, Alonzi DS, Tang W, Tyrrell BE, Hill ML, Caputo AT, Killingbeck SS, Beatty PR, Harris E, Iwaki R, Kinami K, Ide D, Kiappes JL, Kato A, Buck MD, King K, Eddy W, Khaliq M, Sampath A, Treston AM, Dwek RA, Enterlein SG, Miller JL, Zitzmann N, Ramstedt U, Shresta S.

Antiviral Res. 2016 May;129:93-98. doi: 10.1016/j.antiviral.2016.03.001. Epub 2016 Mar 3.

9.

Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination.

Beatty PR, Puerta-Guardo H, Killingbeck SS, Glasner DR, Hopkins K, Harris E.

Sci Transl Med. 2015 Sep 9;7(304):304ra141. doi: 10.1126/scitranslmed.aaa3787.

PMID:
26355030
10.

A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.

Milligan GN, Sarathy VV, Infante E, Li L, Campbell GA, Beatty PR, Harris E, Barrett AD, Bourne N.

PLoS One. 2015 May 4;10(5):e0125476. doi: 10.1371/journal.pone.0125476. eCollection 2015.

11.

Innate immunity to dengue virus infection and subversion of antiviral responses.

Green AM, Beatty PR, Hadjilaou A, Harris E.

J Mol Biol. 2014 Mar 20;426(6):1148-60. doi: 10.1016/j.jmb.2013.11.023. Epub 2013 Dec 3. Review.

12.

Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo.

Miller JL, Lachica R, Sayce AC, Williams JP, Bapat M, Dwek R, Beatty PR, Harris E, Zitzmann N.

Antimicrob Agents Chemother. 2012 Dec;56(12):6379-86. doi: 10.1128/AAC.01554-12. Epub 2012 Oct 15.

13.

Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Zompi S, Santich BH, Beatty PR, Harris E.

J Immunol. 2012 Jan 1;188(1):404-16. doi: 10.4049/jimmunol.1102124. Epub 2011 Nov 30.

14.

On-chip magnetic separation of superparamagnetic beads for integrated molecular analysis.

Florescu O, Wang K, Au P, Tang J, Harris E, Beatty PR, Boser BE.

J Appl Phys. 2010 Mar 1;107(5):54702. Epub 2010 Mar 12.

15.

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E.

PLoS Pathog. 2010 Feb 12;6(2):e1000790. doi: 10.1371/journal.ppat.1000790.

16.

A mouse model for studying dengue virus pathogenesis and immune response.

Williams KL, Zompi S, Beatty PR, Harris E.

Ann N Y Acad Sci. 2009 Sep;1171 Suppl 1:E12-23. doi: 10.1111/j.1749-6632.2009.05057.x. Erratum in: Ann N Y Acad Sci. 2009 Oct;1179:234.

PMID:
19751398
17.

Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining.

Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, McKerrow JH, Beatty PR, Harris E.

Am J Trop Med Hyg. 2009 Mar;80(3):416-24.

PMID:
19270292
18.

Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.

Kyle JL, Balsitis SJ, Zhang L, Beatty PR, Harris E.

Virology. 2008 Oct 25;380(2):296-303. doi: 10.1016/j.virol.2008.08.008. Epub 2008 Sep 6.

19.

Dengue virus infects macrophages and dendritic cells in a mouse model of infection.

Kyle JL, Beatty PR, Harris E.

J Infect Dis. 2007 Jun 15;195(12):1808-17. Epub 2007 May 9.

PMID:
17492597
20.

Murine model for dengue virus-induced lethal disease with increased vascular permeability.

Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E.

J Virol. 2006 Oct;80(20):10208-17.

21.

A novel magnetic bead bioassay platform using a microchip-based sensor for infectious disease diagnosis.

Aytur T, Foley J, Anwar M, Boser B, Harris E, Beatty PR.

J Immunol Methods. 2006 Jul 31;314(1-2):21-9. Epub 2006 Jul 3.

PMID:
16842813
22.

Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice.

Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E.

J Immunol. 2005 Sep 15;175(6):3946-54.

23.
24.

Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.

Beatty PR, Krams SM, Esquivel CO, Martinez OM.

Transplantation. 1998 May 15;65(9):1248-55.

PMID:
9603175
25.

CD30 expression identifies a functional alloreactive human T-lymphocyte subset.

Martinez OM, Villanueva J, Abtahi S, Beatty PR, Esquivel CO, Krams SM.

Transplantation. 1998 May 15;65(9):1240-7.

PMID:
9603174
26.

Human hepatocytes produce an isoform of FAS that inhibits apoptosis.

Krams SM, Fox CK, Beatty PR, Cao S, Villanueva JC, Esquivel CO, Martinez OM.

Transplantation. 1998 Mar 15;65(5):713-21.

PMID:
9521208
27.

Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.

Beatty PR, Krams SM, Martinez OM.

J Immunol. 1997 May 1;158(9):4045-51.

PMID:
9126962
28.
29.

Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp.

Rasmussen SJ, Timms P, Beatty PR, Stephens RS.

Infect Immun. 1996 Jun;64(6):1944-9.

30.

CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway.

Beatty PR, Stephens RS.

J Immunol. 1994 Nov 15;153(10):4588-95.

PMID:
7963531
31.

Identification of Chlamydia trachomatis antigens by use of murine T-cell lines.

Beatty PR, Stephens RS.

Infect Immun. 1992 Nov;60(11):4598-603.

32.

Immune specificity of murine T-cell lines to the major outer membrane protein of Chlamydia trachomatis.

Ishizaki M, Allen JE, Beatty PR, Stephens RS.

Infect Immun. 1992 Sep;60(9):3714-8.

33.

Cysteine-rich outer membrane proteins of Chlamydia trachomatis display compensatory sequence changes between biovariants.

Allen JE, Cerrone MC, Beatty PR, Stephens RS.

Mol Microbiol. 1990 Sep;4(9):1543-50.

PMID:
2287277
35.

Application of the Seibert tryptophane-acid reaction to the serum of malignancy.

RIEGEL C, BEATTY PR.

Cancer Res. 1950 Aug;10(8):495-7. No abstract available.

Supplemental Content

Loading ...
Support Center